"SULFAMATO HYDROXAMIC ACID METALLOPROTEASE INHIBITOR"
Application IN/PCT/2001/1119/CHE published 2005-03-04, filed 2001-08-08
A sulfamato hydroxamic acid compound that inter alia inhibits matrix metalloprotease activity is disclosed as are a process for preparing the same, intermediate compounds useful in those syntheses, and a treatment process that comprises administering a contemplated sulfamato hydroxamic acid compound in a MMP enzyme-inhibiting effective amount to a host having a condition association associated with pathological matrix metalloprotease activity.
Applicant
G D SEARLE & CO.
Corporate Patent Dept.,, P O Box 5110,, Chicago, IL 60680-5110,, USA
Inventor
International Info
Classification: C07D 405/12, A61K 31/445, C07D 211/66, 211/46, 309/08, 401/147, 409/12, 405/14, 491/10. A61K 31/453 & A61P 19/00
Publication Number: PCT/US00/03061
Priority Information
60/119,181 US 1999-02-08